Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR

Ghorashian, S., Kramer, A.M., Onuoha, S., Wright, G., Bartram, J., Richardson, R.T., Albon, S.J., Castro, F., Popova, B., Villanueva, K., Yeung, J., Vetharoy, W., Guvenel, A., Wawrzyniecka, P., Mekkaoui, L., Cheung, G.W., Pinner, D., Chu, J., Lucchini, G., &amp; Silva, J. (2019). Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR. <em>Nature Medicine</em>. https://doi.org/10.1038/s41591-019-0549-5

Ghorashian S, Kramer AM, Onuoha S, Wright G, Bartram J, Richardson RT, et al. Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR. Nature Medicine. 2019. doi:10.1038/s41591-019-0549-5.

@unpublished{sara2019Enhanc, title = {Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR}, author = {Sara Ghorashian and Anne Marijn Kramer and Shimobi Onuoha and Gary Wright and Jack Bartram and Rachael T. Richardson and Sarah J. Albon and Fernanda Castro and Bilyana Popova and Krystle Villanueva and Jenny Yeung and Winston Vetharoy and Aleks Guvenel and Patrycja Wawrzyniecka and Leila Mekkaoui and Gordon Weng-Kit Cheung and Danielle Pinner and Jan Chu and Giovanna Lucchini and Juliana Silva and Oana Ciocârlie and Arina Lazareva and Sarah Inglott and Kimberly Gilmour and Gulrukh Ahsan}, journal = {Nature Medicine}, year = {2019}, doi = {10.1038/s41591-019-0549-5}, }